Literature DB >> 26578066

Ligand-induced expansion of the S1' site in the anthrax toxin lethal factor.

Kimberly M Maize1, Elbek K Kurbanov1, Rodney L Johnson1, Elizabeth Ambrose Amin1, Barry C Finzel2.   

Abstract

The pan class="Species">Bacillus anthracis lethal factor (LF) is one component of a tripartite exotoxin partly responsible for persistent n>n class="Species">anthrax cytotoxicity after initial bacterial infection. Inhibitors of the zinc metalloproteinase have been investigated as potential therapeutic agents, but LF is a challenging target because inhibitors lack sufficient selectivity or possess poor pharmaceutical properties. These structural studies reveal an alternate conformation of the enzyme, induced upon binding of specific inhibitors, that opens a previously unobserved deep pocket termed S1'(∗) which might afford new opportunities to design selective inhibitors that target this subsite.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anthrax; Conformational change; Lethal factor; Ligand-induced; Structure-based drug design; Zinc hydrolase

Mesh:

Substances:

Year:  2015        PMID: 26578066      PMCID: PMC4688111          DOI: 10.1016/j.febslet.2015.11.005

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  34 in total

Review 1.  Anthrax.

Authors:  T C Dixon; M Meselson; J Guillemin; P C Hanna
Journal:  N Engl J Med       Date:  1999-09-09       Impact factor: 91.245

2.  Crystal structure of the anthrax lethal factor.

Authors:  A D Pannifer; T Y Wong; R Schwarzenbacher; M Renatus; C Petosa; J Bienkowska; D B Lacy; R J Collier; S Park; S H Leppla; P Hanna; R C Liddington
Journal:  Nature       Date:  2001-11-08       Impact factor: 49.962

3.  The structural basis for substrate and inhibitor selectivity of the anthrax lethal factor.

Authors:  Benjamin E Turk; Thiang Yian Wong; Robert Schwarzenbacher; Emily T Jarrell; Stephen H Leppla; R John Collier; Robert C Liddington; Lewis C Cantley
Journal:  Nat Struct Mol Biol       Date:  2003-12-29       Impact factor: 15.369

4.  Coot: model-building tools for molecular graphics.

Authors:  Paul Emsley; Kevin Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2004-11-26

5.  Crystal structures of MMP-1 and -13 reveal the structural basis for selectivity of collagenase inhibitors.

Authors:  B Lovejoy; A R Welch; S Carr; C Luong; C Broka; R T Hendricks; J A Campbell; K A Walker; R Martin; H Van Wart; M F Browner
Journal:  Nat Struct Biol       Date:  1999-03

6.  Randomized phase III trial of marimastat versus placebo in patients with metastatic breast cancer who have responding or stable disease after first-line chemotherapy: Eastern Cooperative Oncology Group trial E2196.

Authors:  Joseph A Sparano; Patricia Bernardo; Patricia Stephenson; William J Gradishar; James N Ingle; Stanley Zucker; Nancy E Davidson
Journal:  J Clin Oncol       Date:  2004-12-01       Impact factor: 44.544

Review 7.  Anthrax toxin.

Authors:  R John Collier; John A T Young
Journal:  Annu Rev Cell Dev Biol       Date:  2003       Impact factor: 13.827

8.  Identification of small molecule inhibitors of anthrax lethal factor.

Authors:  Rekha G Panchal; Ann R Hermone; Tam Luong Nguyen; Thiang Yian Wong; Robert Schwarzenbacher; James Schmidt; Douglas Lane; Connor McGrath; Benjamin E Turk; James Burnett; M Javad Aman; Stephen Little; Edward A Sausville; Daniel W Zaharevitz; Lewis C Cantley; Robert C Liddington; Rick Gussio; Sina Bavari
Journal:  Nat Struct Mol Biol       Date:  2003-12-29       Impact factor: 15.369

9.  The effect of adjunctive low-dose doxycycline therapy on clinical parameters and gingival crevicular fluid matrix metalloproteinase-8 levels in chronic periodontitis.

Authors:  Gülnur Emingil; Gül Atilla; Timo Sorsa; Hanne Luoto; Levent Kirilmaz; Haluk Baylas
Journal:  J Periodontol       Date:  2004-01       Impact factor: 6.993

Review 10.  The roles of anthrax toxin in pathogenesis.

Authors:  Mahtab Moayeri; Stephen H Leppla
Journal:  Curr Opin Microbiol       Date:  2004-02       Impact factor: 7.934

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.